Increased forebrain <scp>EAAT3</scp> expression confers resilience to chronic stress
Depression is a disabling and highly prevalent psychiatric illness. Multiple studies have linked glutamatergic dysfunction with the pathophysiology of depression, but the exact alterations in the glutamatergic system that contribute to depressive-like behaviors are not fully understood. Recent evidence suggests that a decreased level in neuronal glutamate transporter (EAAT3), known to control glutamate levels and limit the activation of glutamate receptors at synaptic sites, may contribute to the manifestation of a depressive phenotype. Here, we tested the possibility that increased EAAT3 expression at excitatory synapses could reduce the susceptibility of mice to develop depressive-like behaviors when challenged to a 5-week unpredictable chronic mild stress (UCMS) protocol. Mice overexpressing EAAT3 in the forebrain (EAAT3<sup>glo</sup>/CMKII) and control littermates (EAAT3<sup>glo</sup>) were assessed for depressive-like behaviors and long-term memory performance after being subjected to UCMS conditions. We found that, after UCMS, EAAT3<sup>glo</sup>/CMKII mice did not exhibit depressive-like behaviors or memory alterations observed in control mice. Moreover, we found that EAAT3<sup>glo</sup>/CMKII mice did not show alterations in phasic dopamine release in the nucleus accumbens neither in long-term synaptic plasticity in the CA1 region of the hippocampus after UCMS, as observed in control littermates. Altogether these results suggest that forebrain EAAT3 overexpression may be related to a resilient phenotype, both at behavioral and functional level, to the deleterious effect of chronic stress, highlighting the importance of neuronal EAAT3 in the pathophysiology of depressive-like behaviors.
Authors
- Ramón Sotomayor‐Zárate (ORCID: https://orcid.org/0000-0002-1239-5367)
- Sebastián F. Estay (ORCID: https://orcid.org/0000-0001-8114-023X)
- Pablo R. Moya (ORCID: https://orcid.org/0000-0001-6409-1544)
- Alejandro Alcaino (ORCID: https://orcid.org/0009-0006-7876-5662)
- Vissente Tapia‐Cuevas (ORCID: https://orcid.org/0009-0004-3884-2972)
- Nicolás M. Ardiles (ORCID: https://orcid.org/0009-0008-4997-8524)
- Victoria B. Velásquez (ORCID: https://orcid.org/0009-0007-2710-6357)
- Andrés E. Chávez (ORCID: https://orcid.org/0000-0001-8795-9238)
Institutions
- University of Valparaíso (CL)
Publication Details
- Journal
- Journal of Neurochemistry
- Published
- 2024-09-08
- DOI
- https://doi.org/10.1111/jnc.16216
- Citations
- 1
- Primary Topic
- Neuroscience and Neuropharmacology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.27
Funders
- Universidad de Valparaíso
- Agencia Nacional de Investigación y Desarrollo